Financial reports
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
10-Q
2021 Q1
Quarterly report
13 May 21
10-K
2020 FY
Annual report
18 Mar 21
10-Q
2020 Q3
Quarterly report
12 Nov 20
Current reports
8-K
Material Modifications to Rights of Security Holders
24 Mar 23
8-K
Departure of Directors or Certain Officers
23 Mar 23
8-K
Entry into a Material Definitive Agreement
15 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Mar 23
8-K
Entry into a Material Definitive Agreement
9 Feb 23
8-K
Departure of Directors or Certain Officers
3 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Feb 23
8-K
Departure of Directors or Certain Officers
24 Jan 23
8-K
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
23 Dec 22
8-K
Metacrine Reports Third-quarter 2022 Results
14 Nov 22
Registration and prospectus
15-12G
Securities registration termination
24 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
23 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
23 Mar 23
POS AM
Prospectus update (post-effective amendment)
3 Mar 23
25-NSE
Exchange delisting
3 Mar 23
425
Business combination disclosure
14 Nov 22
425
Business combination disclosure
28 Sep 22
425
Business combination disclosure
27 Sep 22
425
Business combination disclosure
26 Sep 22
425
Business combination disclosure
7 Sep 22
Proxies
DEF 14A
Definitive proxy
13 Feb 23
PRE 14A
Preliminary proxy
24 Jan 23
DEFA14A
Additional proxy soliciting materials
14 Dec 22
DEFM14A
Proxy related to merger
10 Nov 22
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
Other
EFFECT
Notice of effectiveness
8 Mar 23
EFFECT
Notice of effectiveness
18 Oct 21
CORRESP
Correspondence with SEC
13 Oct 21
UPLOAD
Letter from SEC
12 Oct 21
CERT
Certification of approval for exchange listing
16 Sep 20
EFFECT
Notice of effectiveness
16 Sep 20
CORRESP
Correspondence with SEC
14 Sep 20
UPLOAD
Letter from SEC
14 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
Ownership
4
Preston Klassen
24 Mar 23
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 23
SC 13G/A
BML Investment Partners, L.P.
8 Feb 23
4
Michael York
27 Jan 23
4
Preston Klassen
27 Jan 23
4
Braden Michael Leonard
21 Dec 22
SC 13G
TANG CAPITAL PARTNERS LP
19 Dec 22
SC 13D
BML Investment Partners, L.P.
8 Dec 22
4
Braden Michael Leonard
9 Nov 22
4
Braden Michael Leonard
31 Oct 22